Investigation of the Effects of Obesity Surgery on Appetitive Behaviour
Primary Purpose
Roux-en-Y Bariatric Surgery
Status
Completed
Phase
Not Applicable
Locations
Ireland
Study Type
Interventional
Intervention
Octreotide
Saline
Sponsored by

About this trial
This is an interventional health services research trial for Roux-en-Y Bariatric Surgery focused on measuring RYGB, Bariatric surgery, Taste, Reward, Food behaviour, Gut hormones
Eligibility Criteria
Inclusion Criteria:
- Gastric bypass surgery since at least 6 months
Exclusion Criteria:
- serious illness
- pregnancy or breast feeding
- more than three alcoholic drinks per day
- substance abuse
- psychiatric illness
- significant longstanding heart disease or heart intervention (for example, patients who have had heart attacks, have pacemakers or have had heart surgery)
Sites / Locations
- University College Dublin Clinical Research Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Octreotide
Saline
Arm Description
One subcutaneous injection - 1 mL
One subcutaneous injection - 1 mL
Outcomes
Primary Outcome Measures
Progressive ratio breakpoint
In the Progressive ratio task, the participants click a computer mouse in order to obtain a sweet/fat food reward. The effort required to obtain a reward is progressively increased. The breakpoint refers to the point at which the reward value of the food stimulus is lower than the effort necessary to obtain it and the participant stops pressing the button.
Secondary Outcome Measures
Subjective ratings
Hunger, fullness, desire in eating and nausea state will be assessed using Visual Analogue Scales (VAS).
Gut hormones level
GLP-1, ghrelin, leptin and insulin levels will be measured.
Full Information
NCT ID
NCT02010385
First Posted
December 9, 2013
Last Updated
May 20, 2022
Sponsor
University College Dublin
1. Study Identification
Unique Protocol Identification Number
NCT02010385
Brief Title
Investigation of the Effects of Obesity Surgery on Appetitive Behaviour
Official Title
Investigation of the Effects of Obesity Surgery on Appetitive Behaviour - Impact of Gut Hormones
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
February 2013 (undefined)
Primary Completion Date
June 2018 (Actual)
Study Completion Date
June 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University College Dublin
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Among all the existing ways to treat obesity (lifestyle, pharmacological), Roux-en-Y gastric bypass (RYGB) surgery is currently the most effective. It results in long term weight loss maintenance, significant remission of obesity-related comorbidities and decreased overall mortality. It also induces changes in gastrointestinal hormones responses, with an increase of anorexigenic hormones GLP-1, and PYY.
Although successful, the mechanisms for RYGB-induced weight loss are not completely understood. The RYGB does result in increased satiation, decreased calorie intake and decreased preferences for sweet and fatty foods. Previous work from our lab has shown using progressive ratio task (PRT) that RYGB specifically decreases the appetitive behaviour for sweet and fat stimuli but not for vegetables. The reasons for this change in appetitive behaviour after the surgery remain unknown. They may be triggered by changes in gut hormones, conditioned taste aversion (negative post-ingestive effects) or changes in serum bile acids levels.
This study aims to assess whether RGYB-induced gut hormone changes contribute to the decrease in appetitive behaviour for sweet and fatty foods observed after the surgery.
This is a double blind controlled study comparing the effect of blocking gut hormones with somatostatin analogue (octreotide) on the appetitive behaviour for sweet-fat candies will be carried out. Appetitive behaviour will be measured using the progressive ratio task.
The investigators hypothesize that blocking the gut hormones in obese patients with RYGB will increase their appetitive behaviour for sweet-fat candies.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Roux-en-Y Bariatric Surgery
Keywords
RYGB, Bariatric surgery, Taste, Reward, Food behaviour, Gut hormones
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Octreotide
Arm Type
Active Comparator
Arm Description
One subcutaneous injection - 1 mL
Arm Title
Saline
Arm Type
Placebo Comparator
Arm Description
One subcutaneous injection - 1 mL
Intervention Type
Drug
Intervention Name(s)
Octreotide
Other Intervention Name(s)
Octreotide 100 micrograms/1ml - solution for injection - Hospira - Q64021
Intervention Type
Drug
Intervention Name(s)
Saline
Other Intervention Name(s)
Sodium chloride 0.9% W/V injection BP - Fannin - PL 24598/0002
Primary Outcome Measure Information:
Title
Progressive ratio breakpoint
Description
In the Progressive ratio task, the participants click a computer mouse in order to obtain a sweet/fat food reward. The effort required to obtain a reward is progressively increased. The breakpoint refers to the point at which the reward value of the food stimulus is lower than the effort necessary to obtain it and the participant stops pressing the button.
Time Frame
One hour
Secondary Outcome Measure Information:
Title
Subjective ratings
Description
Hunger, fullness, desire in eating and nausea state will be assessed using Visual Analogue Scales (VAS).
Time Frame
One hour
Title
Gut hormones level
Description
GLP-1, ghrelin, leptin and insulin levels will be measured.
Time Frame
One hour
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Gastric bypass surgery since at least 6 months
Exclusion Criteria:
serious illness
pregnancy or breast feeding
more than three alcoholic drinks per day
substance abuse
psychiatric illness
significant longstanding heart disease or heart intervention (for example, patients who have had heart attacks, have pacemakers or have had heart surgery)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carel le Roux, Pr, MD
Organizational Affiliation
UCD Conway institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
University College Dublin Clinical Research Centre
City
Dublin
ZIP/Postal Code
Dublin 4
Country
Ireland
12. IPD Sharing Statement
Citations:
PubMed Identifier
22836034
Citation
Miras AD, Jackson RN, Jackson SN, Goldstone AP, Olbers T, Hackenberg T, Spector AC, le Roux CW. Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am J Clin Nutr. 2012 Sep;96(3):467-73. doi: 10.3945/ajcn.112.036921. Epub 2012 Jul 25.
Results Reference
background
Learn more about this trial
Investigation of the Effects of Obesity Surgery on Appetitive Behaviour
We'll reach out to this number within 24 hrs